Patents Assigned to ImmuSmol SAS
  • Patent number: 10697985
    Abstract: The present invention telates to a method for detecting small molecular analytes in a sample, which method comprises derivatizing at least one small molecular analyte or at least one carrier molecule, in such way that one can bind to the other, thus forming at least one analyte-carrier complex, adding a detection immunoligand that s binds to the analyte-carrier complex, and detecting the small molecular analyte.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: June 30, 2020
    Assignee: IMMUSMOL SAS
    Inventor: Alban Bessede
  • Publication number: 20170219592
    Abstract: The present invention relates to a method of predicting the therapeutic efficacy of at least one therapy approach in the treatment of a neoplastic disease in a patient. The method comprises the following steps: a) Determining the presence or concentration of at least one enzyme or metabolite of the Kynurenine pathway in a patient sample, and b) Concluding, from step a), whether the at least one therapy approach will be therapeutically effective in the treatment of the neoplastic disease.
    Type: Application
    Filed: July 24, 2015
    Publication date: August 3, 2017
    Applicant: ImmuSmol SAS
    Inventor: Alban BESSEDE
  • Publication number: 20160356799
    Abstract: The present invention telates to a method for detecting small molecular analytes in a sample, which method comprises derivatizing at least one small molecular analyte or at least one carrier molecule, in such way that one can bind to the other, thus forming at least one analyte-carrier complex, adding a detection immunoligand that s binds to the analyte-carrier complex, and detecting the small molecular analyte.
    Type: Application
    Filed: June 23, 2014
    Publication date: December 8, 2016
    Applicant: IMMUSMOL SAS
    Inventor: Alban Bessede
  • Publication number: 20150175712
    Abstract: The present invention relates to a modulator of an enzyme and/or a metabolite of the kynurenine pathway (FIG. 18).
    Type: Application
    Filed: June 21, 2013
    Publication date: June 25, 2015
    Applicant: ImmuSmol SAS
    Inventor: Alban Bessède